Boobalan Pachaiyappan Stock Analyst Profile - Roth Capital Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Boobalan Pachaiyappan

    Stock Analyst at Roth Capital

    (3.28)
    # 2788
    Out of 5,478 analysts
    20
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology
    9 Stocks
    Name Action PT Current % Upside Ratings Updated
    RVPH Reviva Pharmaceutica...
    Reiterates: Buy
    7 3
    		n/a n/a 2 Aug 18, 2025
    LGVN Longeveron
    Maintains: Buy
    10 3
    		0.79 279.75% 2 Aug 15, 2025
    GANX Gain Therapeutics
    Maintains: Buy
    7 6
    		1.66 261.45% 3 Aug 13, 2025
    CRVO CervoMed
    Reiterates: Buy
    20 16
    		8.85 80.79% 4 Aug 12, 2025
    CAPR Capricor Therapeutic...
    Maintains: Buy
    31 12
    		6.36 88.68% 2 Jul 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Strong Buy
    92 116
    		106.43 8.99% 2 Jun 18, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    12 9
    		3.47 159.37% 2 Jun 18, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    12 11
    		3.95 178.48% 2 May 19, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    29
    		5.28 449.24% 1 Dec 5, 2024